Doctors told Don Wright he had five years to live when he was diagnosed with multiple myeloma in 2003. Instead…
Articles by Inês Martins, PhD
The U.S. Food and Drug Administration (FDA) has accepted a supplemental biologics license application (sBLA) seeking to expand the currently…
The U.S. Federal Drug Administration has approved a combination of the immunotherapies Darzalex (daratumumab), Pomalyst (pomalidomide) and dexamethasone as a…
Massachusetts–based Karyopharm Therapeutics announced that the first patient was dosed in its pivotal…
John Theurer Cancer Center and MedStar Georgetown University Hospital have announced the completion of the 100th blood stem cell…
Caris Life Sciences is collaborating with the National Cancer Institute (NCI) to identify patients eligible to participate in the…
The first research program dedicated to the early detection and prevention of multiple myeloma will be under way soon, thanks to…
Patients with certain kinds of relapsed or refractory multiple myelomas can enroll in a clinical trial assessing a combination of …
Patients with advanced multiple myeloma who received three or more lines of therapy have…
The non-profit cancer-therapy consulting group Patient Power is hailing a District of Columbia law that established patient co-pay ceilings on specialty…